Clinical Trial

Risk Communication in African American Smokers

Study Description

Risk Communication in African American Smokers

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - HRHA

participants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (~50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (~90%).

Behavioral - LRLA

participants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (~7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (~10%).

Behavioral - HRLA

participants will receive "High Risk, Low Ancestry (HRLA)" hypothetical

Behavioral - LRHA

participants will receive "Low Risk, High Ancestry (HRLA)" hypothetical

Additional Information

Official Study Title

Nicotine Dependence and Lung Cancer Genetics in African Americans

Clinical Trial ID

NCT04084561

ParticipAid ID

eXDKAe